IBC Meeting Minutes

To maximally meet the transparency aims of the NIH Guidelines, on June 1, 2025:

NIH expects that approved meeting minutes from all IBC meetings occurring on, or after this date will be posted publicly on an institutional website. It is NIH's expectation that minutes will be posted immediately after approval and once all appropriate and allowable redactions have been made. Please note that the provisions of this notice only apply to meetings taking place on, or after June 1, 2025.  IBC meetings take place only as needed.

Contact Support: [email protected]

Meeting Minutes by Date:

• June, 2025
• July, 2025
• Aug, 2025 (for instance)

Institutional Biosafety Committee Background:

All research, teaching, and studies at Oakland University that involve recombinant DNA, infectious agents, and/or cultured cell lines must be approved by the Institutional Biosafety Committee (IBC) prior to any work performed in the laboratory.

• Human/Primate derived materials
• Bloodborne Pathogens
• Recombinant DNA
• Infection agents including:
• Bacteria
• Virus
• Fungi
• Prion
• Biologically-derived toxins
• Cultured cell lines

On behalf of the institution, the IBC is responsible for:

• Reviewing research conducted at (or sponsored by) the institution for compliance, and approving only those research projects that are found to conform to the NIH Guidelines.
• Reviews shall include: (i) independent assessment of the containment levels required for the proposed research, and (ii) assessment of the facilities, procedures, practices, and training and expertise of personnel involved.
• Notifying the Principal Investigator of the results of the IBC's review and approval.
• Periodically reviewing recombinant DNA research conducted at the institution to ensure compliance with the NIH Guidelines.
• Adopting emergency plans covering accidental spills and personnel contamination resulting from recombinant DNA research.
• Reporting any significant problems with or violations of the NIH Guidelines and any significant research-related accidents or illnesses to the appropriate institutional official and NIH/OBA.
• The Institutional Biosafety Committee may not authorize initiation of experiments that are not explicitly covered by the NIH Guidelines, until NIH establishes the containment requirement.